Skip Navigation Links
U.S. flag An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Request For Applications (RFAs)

The NINR invites grant proposals in the following defined areas of research. RFAs are one-time opportunities with one submission date. The RFA is closed after its expiration date. All RFAs, active or inactive may be viewed in current or previous issues of the NIH Guide for Grants and Contracts
Displaying 1 - 11 of 11
Title: HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required)
Announcement Number: RFA-NS-22-002
Release Date: Friday, October 8, 2021
Expiration Date: Friday, December 10, 2021
Activity Code: R61/R33
Title: Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
Announcement Number: RFA-OD-20-003
Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R61/R33
Title: INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
Announcement Number: RFA-OD-20-004
Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R21
Title: Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
Announcement Number: RFA-OD-20-003
Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R61/R33
Title: INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
Announcement Number: RFA-OD-20-004
Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R21
Title: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)
Announcement Number: RFA-NS-20-008
Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R41/R42
Title: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-009
Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R41/R42
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
Announcement Number: RFA-NS-20-010
Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-011
Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-011
Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
Announcement Number: RFA-OD-19-029
Release Date: Friday, September 27, 2019
Expiration Date: Saturday, November 27, 2021
Activity Code: R01
Arrow Up Back to Top